1Giralt S.Reduced-intensity conditioning regimens for hematologic malignancies:what have we learned over the last 10 years[J]?Hematology(Am Soc Hematol Educ Program),2005:384-389. 被引量：1
2Alyea EP,Kim HT,Ho V,et al.Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age[J].Blood,2005,105(4):1810-1814. 被引量：1
3Schlenk RF,Harmann F,Hensel M,et al.Less intense conditioning with fludarabine,cyclophosphamide,idarubicin and etoposide(FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia[J].Leukemia,2002,16(4):581-586. 被引量：1
1Murata M, Harada M, Kato S, et al. Peripheral blood stem cell mobilization and apherasis: analysis of adverse events in 94 normal donors.Bone Marrow Transolantation, 1999, 24(10) : 1065 - 1071. 被引量：1
2Gutierrez-Delgado F, Bensinger W. Safety of granulocyte colony-stimulating factor in normal donors. Curr Opin Hematol, 2001, 8(3): 155 -160. 被引量：1
3Mizano S, Okamura T, lwasaki H, et al. Hypercoagulable state following transfusion of granulocyte obtained from granulocyte colony-stimulating factor-stimulated donors, lnt J Hematol, 2000, 72 ( 1 ) : 571 - 573. 被引量：1
4Martinez C, Urbano-lspizua A, Rozman C, et al. Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors. Ann Hematol, 1996, 71 (4) : 269 - 272. 被引量：1
5Froberg MK, Garg UC, Stroncet DF, et al. Changes in serum osteocalcin and bone-specific alkaline phosphatase are associated with bone painn donors receiving granulocyte~colony-stimulating factor for peripheral blood stem and progenitor cell collection. Transfusion, 1999, 39 (4):410-414. 被引量：1
6Froberg MK, Garg UC, Stroncet DF, et al. Changes in serum osteocalcin and bone-specific alkaline phosphatase are associated with bone pain in donors receiving granulocyte-colony-stimulating factor for peripheral blood stem and progenitor cell collection. 被引量：1
7Murata M, Harada M, Kato S, et al. Peripheral blood stem cell mobilization and apherasis: analysis of adverse events in 94 normal donors.Bone Marrow Transplantation, 1999, 24(10): 1065- 1071 被引量：1
8Gutierrez-Delgado F, Bensinger W. Safety of granulocyte colony-stimulating factor in normal donors. Curr Opin Hematol, 2001, 8(3):155-160 被引量：1
9Mizano S, Okamura T, Iwasaki H, et al. Hypercoagulable state following transfusion of granulocyte obtained from granulocyte colony-stimulating factor-stimulated donors. Int J Hematol, 2000, 72 ( 1 ): 571 - 573 被引量：1
10Maninez C, Urbano-Ispizua A, Rozman C, et al. Effects of G-CSFadministration and peripheral blood progenitor cell collection in 20 healthy donors. Ann Hematol, 1996, 71 (4): 269 - 272 被引量：1
6Deschler B,de W itte T, M ertels mann R, et al. Treatment decision-making for older patients with high-risk myelodys-plastic syndrome or acute myeloid leukemia problems and approaches[J].Hematologica,2006,91( 11 ) : 1513-1522. 被引量：1
7Larson RA, Boogaerts M A, Estey E, et ol. Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relap seusing Mylotarg (gemtuzumab ozogamicin) [J]. Leukemia, 2002,16: 1627-1636. 被引量：1
